Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The Pandemic Picture Is Becoming Clearer

The last time Pranay Laharia and Amadi Nze chatted about the COVID-19 pandemic in the summer, it wasn’t clear how much longer the public health crisis would continue. While we’re still not sure the exact date we’ll be able to stop utilizing masks and file back into places like full stadiums for a basketball…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

The last time Pranay Laharia and Amadi Nze chatted about the COVID-19 pandemic in the summer, it wasn’t clear how much longer the public health crisis would continue.

While we’re still not sure the exact date we’ll be able to stop utilizing masks and file back into places like full stadiums for a basketball game, a packed movie theater for a midnight showing or a cramped dive bar for a beer, Laharia said the picture is clearing up.

“There’s been some good news and some not so good news over the last five months. The good news is we have some phenomenal success on the vaccine front,” said Laharia, Director and Equity Health Care Analyst at Barrow Hanley.

The bad news, of course, is the number of cases, which experts expect only to rise as people gather to celebrate the holidays and spend more time inside, where the coronavirus is more likely to spread.

There is, however, a light at the end of the tunnel, with Laharia expecting vaccines from companies like Pfizer and Moderna to turn the tide and possibly even lead to an eradication of the virus, though how long-lasting the protection provided by those vaccines will be is yet to be determined.

Those vaccines utilize messenger RNA to create a spike protein that teaches the body how to attack the virus. Even if it mutates, it won’t take long to tamp down potential flair-ups.

“It’s a real blessing we have the messenger RNA technology ready in time for this pandemic. This pandemic is very, very quick to respond to any changes and mutations,” Lahria said. “Once you have a mutation genetically sequenced, you can take that sequence and tweak your messenger RNA, which is really a synthetic molecule, to produce a different confirmation of the spike protein which would be associated with the mutated virus. You can do that within two to seven days.”

While distribution will pose a challenge, Lahria expects the cold shipment required for the Pfizer vaccine to be easier to handle than some media outlets have made it out to be, with the demand for the vaccine likely to make sure that few retail pharmacies need to store the vaccine for more than the five days it can last in most pharmacy refrigerators.

All that means while the pandemic is at its worst stage at time of writing, we can reasonably hope to be back to something resembling normal life at some point in 2021.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

Most reprocessing audit gaps trace back to training, turnover and leadership

Most reprocessing audit gaps trace back to training, turnover and leadership

Joint Commission findings on its reprocessing standard point mostly to training, turnover, leadership and missing ownership, not sterilizers. CDC epidemiologists and a 2019 review add cleaning verification and manufacturer instructions as the steps to watch. Audit people and process steps as closely as the autoclave.

  • 01Of the Joint Commission's list of reasons hospitals miss reprocessing standard IC.02.02.01, at least eight concern people, priorities and management, so competency records and a named process owner belong in the audit as much as sterilizer logs.
  • 02A structured audit tool that scores compliance step by step, as a 2020 BMC Health Services Research study did across 189 reprocessing cycles, shows where training hours should go; the Nepal hospitals scored best on cleaning and storage and worse on the steps between.

Sep 14, 2026

From Data to Decisions: Leadership, Trust, and AI in Healthcare with Dr. Julia Rehman

Healthcare leaders often struggle to convert abundant data and AI investments into actionable decisions that improve care. Dr. Julia Rehman emphasizes that effective AI integration requires human judgment in the loop, strong governance frameworks, and frontline staff engagement, especially in resource-constrained settings.

  • 01AI should target specific operational challenges like staffing, readmissions, and bed capacity, with humans retaining decision-making authority.
  • 02Few healthcare organizations have governance structures to ensure accountability, audit trails, bias monitoring, and oversight as AI adoption accelerates.
  • 03Data richness without strategic insight and human judgment informed by experience limits the value of technology investments in healthcare.

Sep 14, 2026

Two Radiology Deals Signal Focus on Coverage, Not Scanners

Two Radiology Deals Signal Focus on Coverage, Not Scanners

Colorado Imaging Associates and TRA Medical Imaging announced Sept. 8, 2026 that they are forming Affiliated Radiology to expand physician coverage for a shared health system client, Radiology Business reported. Separately, Align Capital Partners said in late May 2026 it agreed to acquire Boise-based Heritage Imaging, a mobile diagnostic imaging provider operating in 14 states, according to Radiology Business.

  • 01Affiliated Radiology was formed by combining Colorado Imaging Associates and TRA Medical Imaging to expand physician coverage for a shared health system client.
  • 02Heritage Imaging operates mobile diagnostic units across 14 states, providing PET-CT, MRI, nuclear medicine, ultrasound and echocardiography to critical access hospitals and community clinics.
  • 03Health system sourcing teams should request service-level commitments, credentialing procedures, cross-location read routing, and PACS/RIS/EHR integration details before contracting with coverage-focused or mobile imaging arrangements.

Sep 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512